Open Label Proof of Concept Study of IV Zoledronic Acid (ZA) 5 mg After Forteo in Postmenopausal Women.
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Proof of concept; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 10 Nov 2006 New trial record.